AIP
IQMDU

Ahrens Investment Partners’s Intelligent Medicine Acquisition Corp. Unit IQMDU Stock Holding History

Ahrens Investment Partners’s Portfolio IQMDU Stock Details IQMDU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-900
Closed -$9K – 993
2022
Q2 		$9K Sell
900
-100
-10% -$1.01K ﹤0.01% 679
2022
Q1 		$10K Hold
1,000
– – ﹤0.01% 745
2021
Q4 		$10K Buy
+1,000
New +$10.1K ﹤0.01% 762

Other funds holding IQMDU

Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.76% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
DCM
Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.95% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.34% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.72% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Ahrens Investment Partners's IQMDU Position: Q3 2022 in Review

Ahrens Investment Partners sold out of Intelligent Medicine Acquisition Corp. Unit (IQMDU) in Q3 2022, closing a stake of 900 shares — an estimated $9K sold.

Ahrens Investment Partners first reported a position in IQMDU in Q4 2021 and held it in 3 quarters. The position peaked at $10K in Q1 2022. 20 funds tracked by Wall St. Rank hold IQMDU as of Q3 2022.

  • Ahrens Investment Partners reported no remaining Intelligent Medicine Acquisition Corp. Unit position as of Q3 2022 after selling out during the quarter.
  • Ahrens Investment Partners sold 900 Intelligent Medicine Acquisition Corp. Unit shares in Q3 2022, an estimated $9K.
  • Ahrens Investment Partners first reported a position in Intelligent Medicine Acquisition Corp. Unit in Q4 2021 and held it in 3 quarters.
  • Ahrens Investment Partners's Intelligent Medicine Acquisition Corp. Unit position peaked at $10K in Q1 2022.
  • 20 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Unit as of Q3 2022.

Based on Ahrens Investment Partners's 13F filing for Q3 2022, filed 8 Nov 2022.